Free shipping on all orders over $ 500

 About 1 result found for searched term "1646267-59-5" (0.137 seconds)

Cat.No.  Name Target
M21323 ACT-660602 CXCR
ACT-660602 is an oral chemokine receptor CXCR3 antagonist with an IC50 of 204 nM. It is being developed for use in autoimmune diseases.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.